腫瘍アブレーションの世界市場 - 産業動向と予測（～2030年）

世界の腫瘍アブレーションの市場規模は、2022年の15億685万米ドルから2030年までに42億2,584万米ドルに達し、2023年～2030年の予測期間中にCAGRで13.8%の成長が予測されています。

当レポートでは、世界の腫瘍アブレーション市場について調査分析し、産業動向と予測、セグメント分析、企業プロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 市場セグメンテーション

第3章 エグゼクティブサマリー

第4章 重要考察

• PESTEL分析
• ポーターのファイブフォース分析モデル

第5章 規制の枠組み

• 米国の規制シナリオ
• ドイツの規制シナリオ
• 中国の規制シナリオ
• オーストラリアの規制シナリオ
• ブラジルの規制シナリオ
• サウジアラビアの規制シナリオ

第6章 市場の概要

• 促進要因
  • 世界中でのがんの流行
  • 低侵襲手術に対する外科医と患者の志向の高まり
  • 技術の進歩
  • 意識と教育の向上
• 抑制要因
  • 承認に向けた規制のハードル
  • 限られた臨床エビデンス
• 機会
  • 有利な償還シナリオ
  • 主要市場企業による戦略的取り組み
• 課題
  • 腫瘍を標的とすることの技術的課題
  • 代替の治療法との競合

第7章 世界の腫瘍アブレーション市場：タイプ別

• 概要
• 熱アブレーション
  • 腫瘍アブレーションシステム
  • 画像誘導製品、アクセサリ
• 化学的アブレーション
  • エタノール
  • 酢酸

第8章 世界の腫瘍アブレーション市場：治療タイプ別

• 概要
• 経皮
  • 乳がん
  • 肺がん
  • 前立腺がん
  • 肝臓がん
  • 腎臓がん
  • その他のがん
• 腹腔鏡
  • 乳がん
  • 肺がん
  • 前立腺がん
  • 肝臓がん
  • 腎臓がん
  • その他のがん
• 手術
  • 乳がん
  • 肺がん
  • 前立腺がん
  • 肝臓がん
  • 腎臓がん
  • その他のがん

第9章 世界の腫瘍アブレーション市場：がんタイプ別

• 概要
• 乳がん
• 肺がん
• 前立腺がん
• 肝臓がん
• 腎臓がん
• 骨がん
• その他

第10章 世界の腫瘍アブレーション市場：エンドユーザー別

• 概要
• 病院
• 腫瘍センター
• その他

第11章 世界の腫瘍アブレーション市場：流通チャネル別

• 概要
• 直接入札
• 小売販売

第12章 世界の腫瘍アブレーション市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • ロシア
  • スペイン
  • オランダ
  • スイス
  • ベルギー
  • トルコ
  • その他の欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • インドネシア
  • フィリピン
  • タイ
  • マレーシア
  • シンガポール
  • その他のアジア太平洋
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • アラブ首長国連邦
  • エジプト
  • イスラエル
  • その他の中東・アフリカ

第13章 世界の腫瘍アブレーション市場、企業情勢

• 企業シェア分析：世界
• 企業シェア分析：北米
• 企業シェア分析：欧州
• 企業シェア分析：アジア太平洋

第14章 SWOT分析

第15章 企業プロファイル

• BOSTON SCIENTIFIC CORPORATION
• MEDTRONIC
• OLYMPUS
• STRYKER
• BIOTRONIK
• ANGIODYNAMICS.
• BIOVENTUS LLC.
• BVM MEDICAL LIMITED
• EDAP TMS
• ETHICON, INC.
• HEALTHTRONICS, INC.
• ICECURE MEDICAL
• INSIGHTEC.
• INTEGRA LIFESCIENCES
• MERIT MEDICAL SYSTEMS.
• SONABLATE CORP.
• TERUMO EUROPE NV

第16章 アンケート

第17章 関連レポート

LIST OF TABLES

• TABLE 1 GLOBAL TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 75
• TABLE 2 GLOBAL THERMAL ABLATION IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 76
• TABLE 3 GLOBAL THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 77
• TABLE 4 GLOBAL TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 77
• TABLE 5 GLOBAL RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 78
• TABLE 6 GLOBAL IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 78
• TABLE 7 GLOBAL CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 80
• TABLE 8 GLOBAL CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 80
• TABLE 9 GLOBAL TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 84
• TABLE 10 GLOBAL PERCUTANEOUS IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 85
• TABLE 11 GLOBAL PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 85
• TABLE 12 GLOBAL LAPAROSCOPIC IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 87
• TABLE 13 GLOBAL LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 87
• TABLE 14 GLOBAL SURGICAL IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 88
• TABLE 15 GLOBAL SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 89
• TABLE 16 GLOBAL TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 93
• TABLE 17 GLOBAL BREAST CANCER IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 94
• TABLE 18 GLOBAL LUNG CANCER IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 95
• TABLE 19 GLOBAL PROSTATE CANCER IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 96
• TABLE 20 GLOBAL LIVER CANCER IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 97
• TABLE 21 GLOBAL KIDNEY CANCER IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 98
• TABLE 22 GLOBAL BONE CANCER IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 99
• TABLE 23 GLOBAL OTHERS IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 99
• TABLE 24 GLOBAL TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 103
• TABLE 25 GLOBAL HOSPITALS IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 104
• TABLE 26 GLOBAL ONCOLOGY CENTERS IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 105
• TABLE 27 GLOBAL OTHERS IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 105
• TABLE 28 GLOBAL TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 109
• TABLE 29 GLOBAL DIRECT TENDER IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 110
• TABLE 30 GLOBAL RETAIL SALES IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 111
• TABLE 31 GLOBAL TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 117
• TABLE 32 NORTH AMERICA TUMOR ABLATION MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 122
• TABLE 33 NORTH AMERICA TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 122
• TABLE 34 NORTH AMERICA THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 122
• TABLE 35 NORTH AMERICA TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 123
• TABLE 36 NORTH AMERICA RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 123
• TABLE 37 NORTH AMERICA IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 123
• TABLE 38 NORTH AMERICA CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 124
• TABLE 39 NORTH AMERICA TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 124
• TABLE 40 NORTH AMERICA PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 124
• TABLE 41 NORTH AMERICA LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 125
• TABLE 42 NORTH AMERICA SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 125
• TABLE 43 NORTH AMERICA TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 126
• TABLE 44 NORTH AMERICA TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 126
• TABLE 45 NORTH AMERICA TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 126
• TABLE 46 U.S. TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 127
• TABLE 47 U.S. THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 127
• TABLE 48 U.S. TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 127
• TABLE 49 U.S. RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 128
• TABLE 50 U.S. IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 128
• TABLE 51 U.S. CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 128
• TABLE 52 U.S. TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 128
• TABLE 53 U.S. PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 129
• TABLE 54 U.S. LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 129
• TABLE 55 U.S. SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 130
• TABLE 56 U.S. TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 130
• TABLE 57 U.S. TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 131
• TABLE 58 U.S. TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 131
• TABLE 59 CANADA TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 132
• TABLE 60 CANADA THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 132
• TABLE 61 CANADA TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 132
• TABLE 62 CANADA RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 133
• TABLE 63 CANADA IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 133
• TABLE 64 CANADA CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 133
• TABLE 65 CANADA TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 134
• TABLE 66 CANADA PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 134
• TABLE 67 CANADA LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 135
• TABLE 68 CANADA SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 135
• TABLE 69 CANADA TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 136
• TABLE 70 CANADA TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 136
• TABLE 71 CANADA TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 136
• TABLE 72 MEXICO TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 137
• TABLE 73 MEXICO THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 137
• TABLE 74 MEXICO TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 137
• TABLE 75 MEXICO RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 138
• TABLE 76 MEXICO IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 138
• TABLE 77 MEXICO CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 138
• TABLE 78 MEXICO TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 139
• TABLE 79 MEXICO PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 139
• TABLE 80 MEXICO LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 140
• TABLE 81 MEXICO SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 140
• TABLE 82 MEXICO TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 141
• TABLE 83 MEXICO TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 141
• TABLE 84 MEXICO TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 141
• TABLE 85 EUROPE TUMOR ABLATION MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 146
• TABLE 86 EUROPE TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 146
• TABLE 87 EUROPE THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 147
• TABLE 88 EUROPE TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 147
• TABLE 89 EUROPE RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 147
• TABLE 90 EUROPE IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 148
• TABLE 91 EUROPE CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 148
• TABLE 92 EUROPE TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 148
• TABLE 93 EUROPE PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 149
• TABLE 94 EUROPE LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 149
• TABLE 95 EUROPE SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 150
• TABLE 96 EUROPE TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 150
• TABLE 97 EUROPE TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 151
• TABLE 98 EUROPE TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 151
• TABLE 99 GERMANY TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 152
• TABLE 100 GERMANY THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 152
• TABLE 101 GERMANY TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 152
• TABLE 102 GERMANY RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 153
• TABLE 103 GERMANY IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 153
• TABLE 104 GERMANY CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 153
• TABLE 105 GERMANY TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 154
• TABLE 106 GERMANY PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 154
• TABLE 107 GERMANY LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 155
• TABLE 108 GERMANY SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 155
• TABLE 109 GERMANY TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 156
• TABLE 110 GERMANY TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 156
• TABLE 111 GERMANY TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 156
• TABLE 112 U.K. TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 157
• TABLE 113 U.K. THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 157
• TABLE 114 U.K. TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 157
• TABLE 115 U.K. RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 158
• TABLE 116 U.K. IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 158
• TABLE 117 U.K. CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 158
• TABLE 118 U.K. TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 158
• TABLE 119 U.K. PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 159
• TABLE 120 U.K. LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 159
• TABLE 121 U.K. SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 160
• TABLE 122 U.K. TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 160
• TABLE 123 U.K. TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 161
• TABLE 124 U.K. TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 161
• TABLE 125 FRANCE TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 162
• TABLE 126 FRANCE THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 162
• TABLE 127 FRANCE TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 162
• TABLE 128 FRANCE RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 163
• TABLE 129 FRANCE IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 163
• TABLE 130 FRANCE CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 163
• TABLE 131 FRANCE TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 164
• TABLE 132 FRANCE PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 164
• TABLE 133 FRANCE LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 165
• TABLE 134 FRANCE SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 165
• TABLE 135 FRANCE TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 166
• TABLE 136 FRANCE TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 166
• TABLE 137 FRANCE TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 166
• TABLE 138 ITALY TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 167
• TABLE 139 ITALY THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 167
• TABLE 140 ITALY TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 167
• TABLE 141 ITALY RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 168
• TABLE 142 ITALY IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 168
• TABLE 143 ITALY CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 168
• TABLE 144 ITALY TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 169
• TABLE 145 ITALY PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 169
• TABLE 146 ITALY LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 170
• TABLE 147 ITALY SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 170
• TABLE 148 ITALY TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 171
• TABLE 149 ITALY TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 171
• TABLE 150 ITALY TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 171
• TABLE 151 RUSSIA TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 172
• TABLE 152 RUSSIA THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 172
• TABLE 153 RUSSIA TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 172
• TABLE 154 RUSSIA RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 173
• TABLE 155 RUSSIA IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 173
• TABLE 156 RUSSIA CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 173
• TABLE 157 RUSSIA TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 174
• TABLE 158 RUSSIA PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 174
• TABLE 159 RUSSIA LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 175
• TABLE 160 RUSSIA SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 175
• TABLE 161 RUSSIA TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 176
• TABLE 162 RUSSIA TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 176
• TABLE 163 RUSSIA TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 176
• TABLE 164 SPAIN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 177
• TABLE 165 SPAIN THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 177
• TABLE 166 SPAIN TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 177
• TABLE 167 SPAIN RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 178
• TABLE 168 SPAIN IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 178
• TABLE 169 SPAIN CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 178
• TABLE 170 SPAIN TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 179
• TABLE 171 SPAIN PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 179
• TABLE 172 SPAIN LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 180
• TABLE 173 SPAIN SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 180
• TABLE 174 SPAIN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 181
• TABLE 175 SPAIN TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 181
• TABLE 176 SPAIN TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 181
• TABLE 177 NETHERLANDS TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 182
• TABLE 178 NETHERLANDS THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 182
• TABLE 179 NETHERLANDS TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 182
• TABLE 180 NETHERLANDS RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 183
• TABLE 181 NETHERLANDS IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 183
• TABLE 182 NETHERLANDS CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 183
• TABLE 183 NETHERLANDS TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 184
• TABLE 184 NETHERLANDS PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 184
• TABLE 185 NETHERLANDS LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 185
• TABLE 186 NETHERLANDS SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 185
• TABLE 187 NETHERLANDS TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 186
• TABLE 188 NETHERLANDS TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 186
• TABLE 189 NETHERLANDS TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 186
• TABLE 190 SWITZERLAND TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 187
• TABLE 191 SWITZERLAND THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 187
• TABLE 192 SWITZERLAND TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 187
• TABLE 193 SWITZERLAND RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 188
• TABLE 194 SWITZERLAND IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 188

• TABLE 195 SWITZERLAND CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 188
• TABLE 196 SWITZERLAND TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 189
• TABLE 197 SWITZERLAND PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 189
• TABLE 198 SWITZERLAND LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 190
• TABLE 199 SWITZERLAND SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 190
• TABLE 200 SWITZERLAND TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 191
• TABLE 201 SWITZERLAND TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 191
• TABLE 202 SWITZERLAND TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 191
• TABLE 203 BELGIUM TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 192
• TABLE 204 BELGIUM THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 192
• TABLE 205 BELGIUM TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 192
• TABLE 206 BELGIUM RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 193
• TABLE 207 BELGIUM IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 193
• TABLE 208 BELGIUM CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 193
• TABLE 209 BELGIUM TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 194
• TABLE 210 BELGIUM PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 194
• TABLE 211 BELGIUM LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 195
• TABLE 212 BELGIUM SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 195
• TABLE 213 BELGIUM TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 196
• TABLE 214 BELGIUM TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 196
• TABLE 215 BELGIUM TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 196
• TABLE 216 TURKEY TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 197
• TABLE 217 TURKEY THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 197
• TABLE 218 TURKEY TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 197
• TABLE 219 TURKEY RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 198
• TABLE 220 TURKEY IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 198
• TABLE 221 TURKEY CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 198
• TABLE 222 TURKEY TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 199
• TABLE 223 TURKEY PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 199
• TABLE 224 TURKEY LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 200
• TABLE 225 TURKEY SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 200
• TABLE 226 TURKEY TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 201
• TABLE 227 TURKEY TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 201
• TABLE 228 TURKEY TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 201
• TABLE 229 REST OF EUROPE TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 202
• TABLE 230 ASIA-PACIFIC TUMOR ABLATION MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 207
• TABLE 231 ASIA-PACIFIC TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 207
• TABLE 232 ASIA-PACIFIC THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 208
• TABLE 233 ASIA-PACIFIC TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 208
• TABLE 234 ASIA-PACIFIC RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 208
• TABLE 235 ASIA-PACIFIC IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 209
• TABLE 236 ASIA-PACIFIC CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 209
• TABLE 237 ASIA-PACIFIC TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 209
• TABLE 238 ASIA-PACIFIC PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 210
• TABLE 239 ASIA-PACIFIC LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 210
• TABLE 240 ASIA-PACIFIC SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 211
• TABLE 241 ASIA-PACIFIC TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 211
• TABLE 242 ASIA-PACIFIC TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 212
• TABLE 243 ASIA-PACIFIC TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 212
• TABLE 244 CHINA TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 213
• TABLE 245 CHINA THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 213
• TABLE 246 CHINA TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 213
• TABLE 247 CHINA RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 214
• TABLE 248 CHINA IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 214
• TABLE 249 CHINA CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 214
• TABLE 250 CHINA TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 215
• TABLE 251 CHINA PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 215
• TABLE 252 CHINA LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 216
• TABLE 253 CHINA SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 216
• TABLE 254 CHINA TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 217
• TABLE 255 CHINA TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 217
• TABLE 256 CHINA TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 217
• TABLE 257 JAPAN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 218
• TABLE 258 JAPAN THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 218
• TABLE 259 JAPAN TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 218
• TABLE 260 JAPAN RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 218
• TABLE 261 JAPAN IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 219
• TABLE 262 JAPAN CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 219
• TABLE 263 JAPAN TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 219
• TABLE 264 JAPAN PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 220
• TABLE 265 JAPAN LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 220
• TABLE 266 JAPAN SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 221
• TABLE 267 JAPAN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 221
• TABLE 268 JAPAN TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 222
• TABLE 269 JAPAN TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 222
• TABLE 270 INDIA TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 223
• TABLE 271 INDIA THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 223
• TABLE 272 INDIA TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 223
• TABLE 273 INDIA RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 224
• TABLE 274 INDIA IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 224
• TABLE 275 INDIA CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 224
• TABLE 276 INDIA TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 225
• TABLE 277 INDIA PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 225
• TABLE 278 INDIA LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 226
• TABLE 279 INDIA SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 226
• TABLE 280 INDIA TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 227
• TABLE 281 INDIA TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 227
• TABLE 282 INDIA TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 227
• TABLE 283 AUSTRALIA TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 228
• TABLE 284 AUSTRALIA THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 228
• TABLE 285 AUSTRALIA TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 228
• TABLE 286 AUSTRALIA RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 229
• TABLE 287 AUSTRALIA IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 229
• TABLE 288 AUSTRALIA CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 229
• TABLE 289 AUSTRALIA TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 230
• TABLE 290 AUSTRALIA PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 230
• TABLE 291 AUSTRALIA LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 231
• TABLE 292 AUSTRALIA SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 231
• TABLE 293 AUSTRALIA TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 232
• TABLE 294 AUSTRALIA TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 232
• TABLE 295 AUSTRALIA TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 232
• TABLE 296 SOUTH KOREA TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 233
• TABLE 297 SOUTH KOREA THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 233
• TABLE 298 SOUTH KOREA TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 233
• TABLE 299 SOUTH KOREA RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 234
• TABLE 300 SOUTH KOREA IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 234
• TABLE 301 SOUTH KOREA CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 234
• TABLE 302 SOUTH KOREA TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 235
• TABLE 303 SOUTH KOREA PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 235
• TABLE 304 SOUTH KOREA LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 236
• TABLE 305 SOUTH KOREA SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 236
• TABLE 306 SOUTH KOREA TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 237
• TABLE 307 SOUTH KOREA TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 237
• TABLE 308 SOUTH KOREA TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 237
• TABLE 309 INDONESIA TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 238
• TABLE 310 INDONESIA THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 238
• TABLE 311 INDONESIA TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 238
• TABLE 312 INDONESIA RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 239
• TABLE 313 INDONESIA IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 239
• TABLE 314 INDONESIA CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 239
• TABLE 315 INDONESIA TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 240
• TABLE 316 INDONESIA PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 240
• TABLE 317 INDONESIA LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 241
• TABLE 318 INDONESIA SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 241
• TABLE 319 INDONESIA TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 242
• TABLE 320 INDONESIA TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 242
• TABLE 321 INDONESIA TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 242
• TABLE 322 PHILIPPINES TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 243
• TABLE 323 PHILIPPINES THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 243
• TABLE 324 PHILIPPINES TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 243
• TABLE 325 PHILIPPINES RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 244
• TABLE 326 PHILIPPINES IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 244
• TABLE 327 PHILIPPINES CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 244
• TABLE 328 PHILIPPINES TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 245
• TABLE 329 PHILIPPINES PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 245
• TABLE 330 PHILIPPINES LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 246
• TABLE 331 PHILIPPINES SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 246
• TABLE 332 PHILIPPINES TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 247
• TABLE 333 PHILIPPINES TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 247
• TABLE 334 PHILIPPINES TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 247
• TABLE 335 THAILAND TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 248
• TABLE 336 THAILAND THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 248
• TABLE 337 THAILAND TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 248
• TABLE 338 THAILAND RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 249
• TABLE 339 THAILAND IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 249
• TABLE 340 THAILAND CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 249
• TABLE 341 THAILAND TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 250
• TABLE 342 THAILAND PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 250
• TABLE 343 THAILAND LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 251
• TABLE 344 THAILAND SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 251
• TABLE 345 THAILAND TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 252
• TABLE 346 THAILAND TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 252
• TABLE 347 THAILAND TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 252
• TABLE 348 MALAYSIA TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 253
• TABLE 349 MALAYSIA THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 253
• TABLE 350 MALAYSIA TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 253
• TABLE 351 MALAYSIA RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 254
• TABLE 352 MALAYSIA IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 254
• TABLE 353 MALAYSIA CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 254
• TABLE 354 MALAYSIA TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 255
• TABLE 355 MALAYSIA PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 255
• TABLE 356 MALAYSIA LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 256
• TABLE 357 MALAYSIA SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 256
• TABLE 358 MALAYSIA TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 257
• TABLE 359 MALAYSIA TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 257
• TABLE 360 MALAYSIA TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 257
• TABLE 361 SINGAPORE TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 258
• TABLE 362 SINGAPORE THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 258
• TABLE 363 SINGAPORE TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 258
• TABLE 364 SINGAPORE RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 259
• TABLE 365 SINGAPORE IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 259
• TABLE 366 SINGAPORE CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 259
• TABLE 367 SINGAPORE TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 260
• TABLE 368 SINGAPORE PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 260
• TABLE 369 SINGAPORE LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 261
• TABLE 370 SINGAPORE SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 261
• TABLE 371 SINGAPORE TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 262
• TABLE 372 SINGAPORE TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 262
• TABLE 373 SINGAPORE TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 262
• TABLE 374 REST OF ASIA PACIFIC TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 263
• TABLE 375 SOUTH AMERICA TUMOR ABLATION MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 268
• TABLE 376 SOUTH AMERICA TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 268
• TABLE 377 SOUTH AMERICA THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 268
• TABLE 378 SOUTH AMERICA TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 269
• TABLE 379 SOUTH AMERICA RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 269
• TABLE 380 SOUTH AMERICA IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 269
• TABLE 381 SOUTH AMERICA CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 270
• TABLE 382 SOUTH AMERICA TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 270
• TABLE 383 SOUTH AMERICA PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 270
• TABLE 384 SOUTH AMERICA LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 271
• TABLE 385 SOUTH AMERICA SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 271
• TABLE 386 SOUTH AMERICA TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 272
• TABLE 387 SOUTH AMERICA TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 272
• TABLE 388 SOUTH AMERICA TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 272
• TABLE 389 BRAZIL TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 273
• TABLE 390 BRAZIL THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 273
• TABLE 391 BRAZIL TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 273
• TABLE 392 BRAZIL RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 274
• TABLE 393 BRAZIL IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 274
• TABLE 394 BRAZIL CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 274
• TABLE 395 BRAZIL TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 275
• TABLE 396 BRAZIL PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 275
• TABLE 397 BRAZIL LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 276
• TABLE 398 BRAZIL SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 276
• TABLE 399 BRAZIL TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 277
• TABLE 400 BRAZIL TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 277
• TABLE 401 BRAZIL TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 277
• TABLE 402 ARGENTINA TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 278
• TABLE 403 ARGENTINA THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 278
• TABLE 404 ARGENTINA TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 278
• TABLE 405 ARGENTINA RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 279
• TABLE 406 ARGENTINA IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 279
• TABLE 407 ARGENTINA CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 279
• TABLE 408 ARGENTINA TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 280
• TABLE 409 ARGENTINA PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 280
• TABLE 410 ARGENTINA LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 281
• TABLE 411 ARGENTINA SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 281
• TABLE 412 ARGENTINA TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 282
• TABLE 413 ARGENTINA TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 282
• TABLE 414 ARGENTINA TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 282
• TABLE 415 REST OF SOUTH AMERICA TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 283
• TABLE 416 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 288
• TABLE 417 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 288
• TABLE 418 MIDDLE EAST AND AFRICA THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 288
• TABLE 419 MIDDLE EAST AND AFRICA TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 289
• TABLE 420 MIDDLE EAST AND AFRICA RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 289
• TABLE 421 MIDDLE EAST AND AFRICA IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 289
• TABLE 422 MIDDLE EAST AND AFRICA CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 290
• TABLE 423 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 290
• TABLE 424 MIDDLE EAST AND AFRICA PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 290
• TABLE 425 MIDDLE EAST AND AFRICA LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 291
• TABLE 426 MIDDLE EAST AND AFRICA SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 291
• TABLE 427 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 292
• TABLE 428 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 292
• TABLE 429 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 292
• TABLE 430 SAUDI ARABIA TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 293

LIST OF FIGURES

• FIGURE 1 GLOBAL TUMOR ABLATION MARKET: SEGMENTATION 41
• FIGURE 2 GLOBAL TUMOR ABLATION MARKET: DATA TRIANGULATION 44
• FIGURE 3 GLOBAL TUMOR ABLATION MARKET: DROC ANALYSIS 45
• FIGURE 4 GLOBAL TUMOR ABLATION MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 46
• FIGURE 5 GLOBAL TUMOR ABLATION MARKET: COMPANY RESEARCH ANALYSIS 46
• FIGURE 6 GLOBAL TUMOR ABLATION MARKET: INTERVIEW DEMOGRAPHICS 47
• FIGURE 7 GLOBAL TUMOR ABLATION MARKET: MARKET END USERS COVERAGE GRID 50
• FIGURE 8 GLOBAL TUMOR ABLATION MARKET: DBMR MARKET POSITION GRID 51
• FIGURE 9 GLOBAL TUMOR ABLATION MARKET: VENDOR SHARE ANALYSIS 52
• FIGURE 10 GLOBAL TUMOR ABLATION MARKET: SEGMENTATION 55
• FIGURE 11 THE RISING PREVALENCE OF CANCER AND GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES ARE EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL TUMOR ABLATION MARKET FROM 2023 TO 2030 56
• FIGURE 12 THE THERMAL ABLATION SEGMENT, IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL TUMOR ABLATION MARKET IN 2023 & 2030 56
• FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL TUMOR ABLATION MARKET AND IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2030 57
• FIGURE 14 NORTH AMERICA IS THE FASTEST-GROWING MARKET FOR GLOBAL TUMOR ABLATION MARKET SERVICE PROVIDERS IN THE FORECAST PERIOD OF 2023 TO 2030 58
• FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE GLOBAL TUMOR ABLATION MARKET 66
• FIGURE 16 GLOBAL TUMOR ABLATION MARKET: BY TYPE, 2022 73
• FIGURE 17 GLOBAL TUMOR ABLATION MARKET: BY TYPE, 2023-2030 (USD MILLION) 74
• FIGURE 18 GLOBAL TUMOR ABLATION MARKET: BY TYPE, CAGR (2023-2030) 74
• FIGURE 19 GLOBAL TUMOR ABLATION MARKET: BY TYPE, LIFELINE CURVE 75
• FIGURE 20 GLOBAL TUMOR ABLATION MARKET: BY TYPES OF TREATMENT, 2022 82
• FIGURE 21 GLOBAL TUMOR ABLATION MARKET: BY TYPES OF TREATMENT, 2023-2030 (USD MILLION) 83
• FIGURE 22 GLOBAL TUMOR ABLATION MARKET: BY TYPES OF TREATMENT, CAGR (2023-2030) 83
• FIGURE 23 GLOBAL TUMOR ABLATION MARKET: BY TYPES OF TREATMENT, LIFELINE CURVE 84
• FIGURE 24 GLOBAL TUMOR ABLATION MARKET: BY CANCER TYPE, 2022 91
• FIGURE 25 GLOBAL TUMOR ABLATION MARKET: BY CANCER TYPE, 2023-2030 (USD MILLION) 92
• FIGURE 26 GLOBAL TUMOR ABLATION MARKET: BY CANCER TYPE, CAGR (2023-2030) 92
• FIGURE 27 GLOBAL TUMOR ABLATION MARKET: BY CANCER TYPE, LIFELINE CURVE 93
• FIGURE 28 GLOBAL TUMOR ABLATION MARKET: BY END USERS, 2022 101
• FIGURE 29 GLOBAL TUMOR ABLATION MARKET: BY END USERS, 2023-2030 (USD MILLION) 102
• FIGURE 30 GLOBAL TUMOR ABLATION MARKET: BY END USERS, CAGR (2023-2030) 102
• FIGURE 31 GLOBAL TUMOR ABLATION MARKET: BY END USERS, LIFELINE CURVE 103
• FIGURE 32 GLOBAL TUMOR ABLATION MARKET: BY DISTRIBUTION CHANNEL, 2022 107
• FIGURE 33 GLOBAL TUMOR ABLATION MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 108
• FIGURE 34 GLOBAL TUMOR ABLATION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 108
• FIGURE 35 GLOBAL TUMOR ABLATION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 109
• FIGURE 36 GLOBAL TUMOR ABLATION MARKET: SNAPSHOT (2022) 114
• FIGURE 37 GLOBAL TUMOR ABLATION MARKET: BY REGION (2022) 115
• FIGURE 38 GLOBAL TUMOR ABLATION MARKET: BY REGION (2023 & 2030) 115
• FIGURE 39 GLOBAL TUMOR ABLATION MARKET: BY REGION (2022 & 2030) 116
• FIGURE 40 GLOBAL TUMOR ABLATION MARKET: BY TYPE (2023-2030) 116
• FIGURE 41 NORTH AMERICA TUMOR ABLATION MARKET: SNAPSHOT (2022) 119
• FIGURE 42 NORTH AMERICA TUMOR ABLATION MARKET: BY COUNTRY (2022) 120
• FIGURE 43 NORTH AMERICA TUMOR ABLATION MARKET: BY COUNTRY (2023 & 2030) 120
• FIGURE 44 NORTH AMERICA TUMOR ABLATION MARKET: BY COUNTRY (2022 & 2030) 121
• FIGURE 45 NORTH AMERICA TUMOR ABLATION MARKET: BY TYPE (2023-2030) 121
• FIGURE 46 EUROPE TUMOR ABLATION MARKET: SNAPSHOT (2022) 143
• FIGURE 47 EUROPE TUMOR ABLATION MARKET: BY COUNTRY (2022) 144
• FIGURE 48 EUROPE TUMOR ABLATION MARKET: BY COUNTRY (2023 & 2030) 144
• FIGURE 49 EUROPE TUMOR ABLATION MARKET: BY COUNTRY (2022 & 2030) 145
• FIGURE 50 EUROPE TUMOR ABLATION MARKET: BY TYPE(2023-2030) 145
• FIGURE 51 ASIA-PACIFIC TUMOR ABLATION MARKET: SNAPSHOT (2022) 204
• FIGURE 52 ASIA-PACIFIC TUMOR ABLATION MARKET: BY COUNTRY (2022) 205
• FIGURE 53 ASIA-PACIFIC TUMOR ABLATION MARKET: BY COUNTRY (2023 & 2030) 205
• FIGURE 54 ASIA-PACIFIC TUMOR ABLATION MARKET: BY COUNTRY (2022 & 2030) 206
• FIGURE 55 ASIA-PACIFIC TUMOR ABLATION MARKET: BY TYPE (2023-2030) 206
• FIGURE 56 SOUTH AMERICA TUMOR ABLATION MARKET: SNAPSHOT (2022) 265
• FIGURE 57 SOUTH AMERICA TUMOR ABLATION MARKET: BY COUNTRY (2022) 266
• FIGURE 58 SOUTH AMERICA TUMOR ABLATION MARKET: BY COUNTRY (2023 & 2030) 266
• FIGURE 59 SOUTH AMERICA TUMOR ABLATION MARKET: BY COUNTRY (2022 & 2030) 267
• FIGURE 60 SOUTH AMERICA TUMOR ABLATION MARKET: BY TYPE (2023-2030) 267
• FIGURE 61 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET: SNAPSHOT (2022) 285
• FIGURE 62 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET: BY COUNTRY (2022) 286
• FIGURE 63 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET: BY COUNTRY (2023 & 2030) 286
• FIGURE 64 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET: BY COUNTRY (2022 & 2030) 287
• FIGURE 65 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET: BY TYPE (2023-2030) 287
• FIGURE 66 GLOBAL TUMOR ABLATION MARKET: COMPANY SHARE 2022 (%) 319
• FIGURE 67 NORTH AMERICA TUMOR ABLATION MARKET: COMPANY SHARE 2022 (%) 320
• FIGURE 68 EUROPE TUMOR ABLATION MARKET: COMPANY SHARE 2022 (%) 321
• FIGURE 69 ASIA-PACIFIC TUMOR ABLATION MARKET: COMPANY SHARE 2022 (%) 322

Global tumor ablation market is expected to reach USD 4,225.84 Million by 2030 from USD 1,506.85 Million in 2022, growing at a CAGR of 13.8% during the forecast period of 2023 to 2030.

Market Segmentation:

Global Tumor Ablation Market, By Type (Thermal Ablation and Chemical Ablation), Types of Treatment (Percutaneous, Laparoscopic, and Surgical), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Liver Cancer, Kidney Cancer, Bone Cancer, and Others), End Users (Hospitals, Oncology Centers, and Others), Distribution Channel (Direct Tender and Retail Sales), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Russia, Spain, Netherlands, Switzerland, Belgium, Turkey, Rest of Europe, China, Japan, India, Australia, South Korea, Indonesia, Philippines, Thailand, Malaysia, Singapore, Rest of Asia Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, South Africa, U.A.E., Egypt, Israel, Rest of Middle East and Africa)- Industry Trends and Forecast to 2030.

Overview of Global Tumor Ablation Market Dynamics :

• Driver
• Increasing prevalence of cancer globally
• Restraint
• Regulatory hurdles for approval
• Opportunity
• Favourable reimbursement scenario

Market Players:

Some of the key players operating in the global tumor ablation market are:

• Boston Scientific Corporation
• Medtronic
• Olympus
• Stryker
• Biotronik
• AngioDynamics
• Bioventus LLC.
• BVM Medical Limited
• EDAP TMS
• Ethicon, Inc.
• HealthTronics, Inc.
• IceCure Medical
• Insightec
• Integra LifeSciences
• Merit Medical Systems
• Sonablate Corp.
• Terumo Europe NV

TABLE OF CONTENTS

1 INTRODUCTION 36

• 1.1 OBJECTIVES OF THE STUDY 36
• 1.2 MARKET DEFINITION 36
• 1.3 OVERVIEW OF THE GLOBAL TUMOR ABLATION MARKET 36
• 1.4 CURRENCY AND PRICING 38
• 1.5 LIMITATIONS 38
• 1.6 MARKETS COVERED 38

2 MARKET SEGMENTATION 41

• 2.1 MARKETS COVERED 41
• 2.2 GEOGRAPHICAL SCOPE 42
• 2.3 YEARS CONSIDERED FOR THE STUDY 43
• 2.4 DBMR TRIPOD DATA VALIDATION MODEL 44
• 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 47
• 2.6 MULTIVARIATE MODELLING 48
• 2.7 TYPE SEGMENT LIFELINE CURVE 49
• 2.8 MARKET END USERS COVERAGE GRID 50
• 2.9 DBMR MARKET POSITION GRID 51
• 2.10 VENDOR SHARE ANALYSIS 52
• 2.11 SECONDARY SOURCES 53
• 2.12 ASSUMPTIONS 53

3 EXECUTIVE SUMMARY 54

4 PREMIUM INSIGHTS 56

• 4.1 PESTEL ANALYSIS 59
• 4.2 PORTER'S FIVE FORCES MODEL 60

5 REGULATORY FRAMEWORK 61

• 5.1 REGULATORY SCENARIO IN THE U.S 61
• 5.2 REGULATORY SCENARIO IN GERMANY 62
• 5.3 REGULATORY SCENARIO IN CHINA 62
• 5.4 REGULATORY SCENARIO IN AUSTRALIA 63
• 5.5 REGULATORY SCENARIO IN BRAZIL 63
• 5.6 REGULATORY SCENARIO IN SAUDI ARABIA 64

6 MARKET OVERVIEW 65

• 6.1 DRIVERS 67
  • 6.1.1 RISING PREVALENCE OF CANCER GLOBALLY 67
  • 6.1.2 INCREASING INCLINATION OF SURGEONS AND PATIENTS TOWARD MINIMALLY INVASIVE PROCEDURES 67
  • 6.1.3 RISING TECHNOLOGICAL ADVANCEMENTS 68
  • 6.1.4 INCREASING AWARENESS AND EDUCATION 68
• 6.2 RESTRAINTS 69
  • 6.2.1 REGULATORY HURDLES FOR APPROVAL 69
  • 6.2.2 LIMITED CLINICAL EVIDENCE 69
• 6.3 OPPORTUNITIES 70
  • 6.3.1 FAVORABLE REIMBURSEMENT SCENARIO 70
  • 6.3.2 STRATEGIC INITIATIVES BY MAJOR MARKET PLAYERS 70
• 6.4 CHALLENGES 71
  • 6.4.1 TECHNICAL CHALLENGES IN TARGETING THE TUMOR 71
  • 6.4.2 COMPETITION FROM ALTERNATIVE TREATMENT MODALITIES 71

7 GLOBAL TUMOR ABLATION MARKET, BY TYPE 72

• 7.1 OVERVIEW 73
• 7.2 THERMAL ABLATION 76
  • 7.2.1 TUMOR ABLATION SYSTEMS 77
    • 7.2.1.1 RADIOFREQUENCY 78
      • 7.2.1.1.1 BIPOLAR 78
      • 7.2.1.1.2 MULTIPOLAR 78
  • 7.2.2 IMAGE GUIDANCE PRODUCTS AND ACCESSORIES 78
    • 7.2.2.1 CT 79
    • 7.2.2.2 MR IMAGING 79
    • 7.2.2.3 FLUOROSCOPY 79
    • 7.2.2.4 OTHERS 79
    • 7.2.2.5 MICROWAVE 79
    • 7.2.2.6 CRYOABLATION 79
    • 7.2.2.7 HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) 79
    • 7.2.2.8 LASER 79
• 7.3 CHEMICAL ABLATION 79
  • 7.3.1 ETHANOL 80
  • 7.3.2 ACETIC ACID 80

8 GLOBAL TUMOR ABLATION MARKET, BY TYPES OF TREATMENT 81

• 8.1 OVERVIEW 82
• 8.2 PERCUTANEOUS 85
  • 8.2.1 BREAST CANCER 86
  • 8.2.2 LUNG CANCER 86
  • 8.2.3 PROSTATE CANCER 86
  • 8.2.4 LIVER CANCER 86
  • 8.2.5 KIDNEY CANCER 86
  • 8.2.6 OTHER CANCERS 86
• 8.3 LAPAROSCOPY 86
  • 8.3.1 BREAST CANCER 87
  • 8.3.2 LUNG CANCER 87
  • 8.3.3 PROSTATE CANCER 87
  • 8.3.4 LIVER CANCER 87
  • 8.3.5 KIDNEY CANCER 88
  • 8.3.6 OTHER CANCERS 88
• 8.4 SURGICAL 88
  • 8.4.1 BREAST CANCER 89
  • 8.4.2 LUNG CANCER 89
  • 8.4.3 PROSTATE CANCER 89
  • 8.4.4 LIVER CANCER 89
  • 8.4.5 KIDNEY CANCER 89
  • 8.4.6 OTHER CANCERS 89

9 GLOBAL TUMOR ABLATION MARKET, BY CANCER TYPE 90

• 9.1 OVERVIEW 91
• 9.2 BREAST CANCER 94
• 9.3 LUNG CANCER 94
• 9.4 PROSTATE CANCER 95
• 9.5 LIVER CANCER 96
• 9.6 KIDNEY CANCER 97
• 9.7 BONE CANCER 98
• 9.8 OTHERS 99

10 GLOBAL TUMOR ABLATION MARKET, BY END USERS 100

• 10.1 OVERVIEW 101
• 10.2 HOSPITALS 104
• 10.3 ONCOLOGY CENTERS 104
• 10.4 OTHERS 105

11 GLOBAL TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL 106

• 11.1 OVERVIEW 107
• 11.2 DIRECT TENDER 110
• 11.3 RETAIL SALES 110

12 GLOBAL TUMOR ABLATION MARKET, BY REGION 112

• 12.1 OVERVIEW 113
• 12.2 NORTH AMERICA 118
  • 12.2.1 U.S. 127
  • 12.2.2 CANADA 132
  • 12.2.3 MEXICO 137
• 12.3 EUROPE 142
  • 12.3.1 GERMANY 152
  • 12.3.2 U.K. 157
  • 12.3.3 FRANCE 162
  • 12.3.4 ITALY 167
  • 12.3.5 RUSSIA 172
  • 12.3.6 SPAIN 177
  • 12.3.7 NETHERLANDS 182
  • 12.3.8 SWITZERLAND 187
  • 12.3.9 BELGIUM 192
  • 12.3.10 TURKEY 197
  • 12.3.11 REST OF EUROPE 202
• 12.4 ASIA PACIFIC 203
  • 12.4.1 CHINA 213
  • 12.4.2 JAPAN 218
  • 12.4.3 INDIA 223
  • 12.4.4 AUSTRALIA 228
  • 12.4.5 SOUTH KOREA 233
  • 12.4.6 INDONESIA 238
  • 12.4.7 PHILIPPINES 243
  • 12.4.8 THAILAND 248
  • 12.4.9 MALAYSIA 253
  • 12.4.10 SINGAPORE 258
  • 12.4.11 REST OF ASIA-PACIFIC 263
• 12.5 SOUTH AMERICA 264
  • 12.5.1 BRAZIL 273
  • 12.5.2 ARGENTINA 278
  • 12.5.3 REST OF SOUTH AMERICA 283
• 12.6 MIDDLE EAST AND AFRICA 284
  • 12.6.1 SAUDI ARABIA 293
  • 12.6.2 SOUTH AFRICA 298
  • 12.6.3 U.A.E. 303
  • 12.6.4 EGYPT 308
  • 12.6.5 ISRAEL 313
  • 12.6.6 REST OF MIDDLE EAST AND AFRICA 318

13 GLOBAL TUMOR ABLATION MARKET, COMPANY LANDSCAPE 319

• 13.1 COMPANY SHARE ANALYSIS: GLOBAL 319
• 13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 320
• 13.3 COMPANY SHARE ANALYSIS: EUROPE 321
• 13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 322

14 SWOT ANALYSIS 323

15 COMPANY PROFILE 324

• 15.1 BOSTON SCIENTIFIC CORPORATION 324
  • 15.1.1 COMPANY SNAPSHOT 324
  • 15.1.2 REVENUE ANALYSIS 324
  • 15.1.3 COMPANY SHARE ANALYSIS 325
  • 15.1.4 PRODUCT PORTFOLIO 325
  • 15.1.5 RECENT DEVELOPMENT 325
• 15.2 MEDTRONIC 326
  • 15.2.1 COMPANY SNAPSHOT 326
  • 15.2.2 REVENUE ANALYSIS 326
  • 15.2.3 COMPANY SHARE ANALYSIS 327
  • 15.2.4 PRODUCT PORTFOLIO 327
  • 15.2.5 RECENT DEVELOPMENT 327
• 15.3 OLYMPUS 328
  • 15.3.1 COMPANY SNAPSHOT 328
  • 15.3.2 REVENUE ANALYSIS 328
  • 15.3.3 COMPANY SHARE ANALYSIS 329
  • 15.3.4 PRODUCT PORTFOLIO 329
  • 15.3.5 RECENT DEVELOPMENT 329
• 15.4 STRYKER 330
  • 15.4.1 COMPANY SNAPSHOT 330
  • 15.4.2 REVENUE ANALYSIS 330
  • 15.4.3 COMPANY SHARE ANALYSIS 331
  • 15.4.4 PRODUCT PORTFOLIO 331
  • 15.4.5 RECENT DEVELOPMENT 331
• 15.5 BIOTRONIK 332
  • 15.5.1 COMPANY SNAPSHOT 332
  • 15.5.2 COMPANY SHARE ANALYSIS 332
  • 15.5.3 PRODUCT PORTFOLIO 333
  • 15.5.4 RECENT DEVELOPMENT 333
• 15.6 ANGIODYNAMICS. 334
  • 15.6.1 COMPANY SNAPSHOT 334
  • 15.6.2 REVENUE ANALYSIS 334
  • 15.6.3 PRODUCT PORTFOLIO 335
  • 15.6.4 RECENT DEVELOPMENT 335
• 15.7 BIOVENTUS LLC. 336
  • 15.7.1 COMPANY SNAPSHOT 336
  • 15.7.2 PRODUCT PORTFOLIO 336
  • 15.7.3 RECENT DEVELOPMENT 336
• 15.8 BVM MEDICAL LIMITED 337
  • 15.8.1 COMPANY SNAPSHOT 337
  • 15.8.2 PRODUCT PORTFOLIO 337
  • 15.8.3 RECENT DEVELOPMENT 337
• 15.9 EDAP TMS 338
  • 15.9.1 COMPANY SNAPSHOT 338
  • 15.9.2 REVENUE ANALYSIS 338
  • 15.9.3 PRODUCT PORTFOLIO 339
  • 15.9.4 RECENT DEVELOPMENT 339
• 15.10 ETHICON, INC. 340
  • 15.10.1 COMPANY SNAPSHOT 340
  • 15.10.2 PRODUCT PORTFOLIO 340
  • 15.10.3 RECENT DEVELOPMENT 340
• 15.11 HEALTHTRONICS, INC. 341
  • 15.11.1 COMPANY SNAPSHOT 341
  • 15.11.2 PRODUCT PORTFOLIO 341
  • 15.11.3 RECENT DEVELOPMENT 341
• 15.12 ICECURE MEDICAL 342
  • 15.12.1 COMPANY SNAPSHOT 342
  • 15.12.2 REVENUE ANALYSIS 342
  • 15.12.3 PRODUCT PORTFOLIO 343
  • 15.12.4 RECENT DEVELOPMENT 343
• 15.13 INSIGHTEC. 344
  • 15.13.1 COMPANY SNAPSHOT 344
  • 15.13.2 PRODUCT PORTFOLIO 344
  • 15.13.3 RECENT DEVELOPMENT 344
• 15.14 INTEGRA LIFESCIENCES 345
  • 15.14.1 COMPANY SNAPSHOT 345
  • 15.14.2 REVENUE ANALYSIS 345
  • 15.14.3 PRODUCT PORTFOLIO 346
  • 15.14.4 RECENT DEVELOPMENT 346
• 15.15 MERIT MEDICAL SYSTEMS. 347
  • 15.15.1 COMPANY SNAPSHOT 347
  • 15.15.2 REVENUE ANALYSIS 347
  • 15.15.3 PRODUCT PORTFOLIO 348
  • 15.15.4 RECENT DEVELOPMENT 348
• 15.16 SONABLATE CORP. 349
  • 15.16.1 COMPANY SNAPSHOT 349
  • 15.16.2 PRODUCT PORTFOLIO 349
  • 15.16.3 RECENT DEVELOPMENT 349
• 15.17 TERUMO EUROPE NV 350
  • 15.17.1 COMPANY SNAPSHOT 350
  • 15.17.2 PRODUCT PORTFOLIO 350
  • 15.17.3 RECENT DEVELOPMENT 350

16 QUESTIONNAIRE 351

17 RELATED REPORTS 354